AZ12216052

CAS No. 1290628-31-7

AZ12216052( —— )

Catalog No. M34169 CAS No. 1290628-31-7

AZ12216052 is a GRP8 antagonist with anxiolytic and anti-inflammatory activity and can be used to study obesity and metabolic disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 79 Get Quote
5MG 117 Get Quote
10MG 188 Get Quote
25MG 319 Get Quote
50MG 474 Get Quote
100MG 660 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AZ12216052
  • Note
    Research use only, not for human use.
  • Brief Description
    AZ12216052 is a GRP8 antagonist with anxiolytic and anti-inflammatory activity and can be used to study obesity and metabolic disorders.
  • Description
    AZ 12216052 is a mGluR8 positive allosteric modulator, and helps mGluR8 modulate signaling inputing to retinal ganglion cells. AZ 12216052 exhibits antianxiety effect.
  • In Vitro
    mGluR8 may modulates the synaptic inputs to retinal ganglion cells.AZ 12216052 (10 μM) enhances the peak excitatory currents of ON-, OFF- currents in ON-OFF-ganglion cells, with a dependent way on the intensity of the light stimuli.AZ 12216052 shows impact of cell differentiation and (0.01-1 μM; 24-48 h) reduces Dox-induced human neuroblastoma SH-SY5Y cell damage partially.AZ 12216052 stimulates proliferation and attenuates staurosporine (St)- and doxorubicin (Dox)-induced toxicity in UN-SH-SY5Y cells.AZ12216052 (10 μM) enhances glutamate activity of human mGluR8b receptor expressed in GHEK cells.Cell Viability Assay Cell Line:UN- and RA-SH-SY5Y cells Concentration:0.01-1 μM Incubation Time:48 hours Result:Increased cell viability at 0.1 μM, and protected undifferentiated neuroblastoma cells against damaging effects of Iri or Cis.
  • In Vivo
    AZ 12216052 (10 mg/kg; i.p.; 2 h prior to testing) reduces measures of anxiety, without affecting the velocity of the mice.AZ12216052 (10 mg/kg; i.p.; single dose) exhibits remaining anxiolytic effects, might involve mGluR4 in mGluR8?/? mice, as the mGluR4 PAM (Positive Allosteric Modulator) VU 0155041 also reduces measures of anxiety in wild-type mice.Animal Model:WT and Apolipoprotein E-deficient (Apoe?/?) mice (C57BL/6J, 2-month-old) in the elevated zero maze Dosage:10 mg/kg Administration:Intraperitoneal injection; singel dose, 2 h prior to testing Result:Reduced measures of anxiety in the elevated zero maze without affecting the velocity of the mice.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1290628-31-7
  • Formula Weight
    392.35
  • Molecular Formula
    C19H22BrNOS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (254.87 mM; Ultrasonic )
  • SMILES
    CCC(C)c1ccc(NC(=O)CSCc2ccc(Br)cc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Reed BT, et al. Differential modulation of retinal ganglion cell light responses by orthosteric and allosteric metabotropic glutamate receptor 8 compounds. Neuropharmacology. 2013 Apr;67:88-94.?
molnova catalog
related products
  • DC260126

    DC260126 is a small-molecule antagonist of FFA1 (GPR40).

  • D-Kynurenine

    D-Kynurenine is a metabolite of D-tryptophan and an agonist of GPR109B. D-Kynurenine activates AhR and promotes the conversion of the epithelium to mesenchyme.

  • hGPR91 antagonist 1

    hGPR91 antagonist 1 is a potent and selective hGPR91 antagonist (IC50: 7 μM).GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.?Current literature indicates that GPR91 plays role in various pathophysiology including renal hypertension, autoimmune disease and retinal angiogenesis.?